Understand how AI-driven tools are allowing veterinarians to match the bug to the drug early
Sponsored by Zoetis
Adam Christman, DVM, MBA: I love what you were just talking about with compliance. I'm curious to get your thoughts Dr. Wolfe on this about compliance and adherence. Do you find that pet parents are more likely to do such things knowing that they have Imagyst and digital cytology available in your clinic?
Shelli Wolfe, DVM, MBA: I do, to reiterate to Dr. Clary’s point. I don't think we realized that we had the Giardia that we have in West Texas, and so they may come in it may be that they're coming in for diarrhea, or maybe they're coming in for immunizations, and they also have diarrhea. And when you have that, the Imagyst has an iPad, and you can take that iPad into the room. And you can actually show the client in the examination room that this is why, you know, hookworms or whipworms or giardia. And rather than just watching and waiting, they'll go ahead, and they'll begin to treat in that moment there. And with ear infections, for, example too now that they've moved to skin cytology, which can include ear cytology, is if we have the Imagyst in the exam room and show this is the yeast or the bacteria on your pet skin or in your ears, then they're more compliant to not only agreeing to allow us to perform these cytologies, but also to their acceptance of treating. And then it helps me know specifically what medication to treat with as well. So I think that the visualization really helps to see we get to point to the bacteria and point to the yeast and point to the giardia. I love that matching the bug to the drug early.
Adam Christman, DVM, MBA: For you and your practice.
Carl Clary, DVM: Same way. It just increases compliance, and also that turnaround time. What I love is that client comes in, they have a problem, we diagnose it, they go home with the solution, not two days from now. I don't have to do phone calls. I don't have to worry about them picking the medicine back up. People are busy. They don't have time to keep coming back and forth to the clinic. And I think it also helps with costs because maybe we haven't, if we diagnose it correctly, we haven't tried three drugs that didn't work and then finally end up with one that works. We're more pinpointed, directed to the actual disease.
Shelli Wolfe, DVM, MBA: That's great. And I think it's better medicine as well, because I can tell you that we practice better fecals because they provide you the kits. So, we're using the appropriate solution. We're centrifuging it and I feel confident too, when I'm treating a diarrhea, that a negative is more likely to be a negative, as opposed to having my technician perform the fecal flotation and maybe not waiting the appropriate amount of time or spending at the appropriate amount of time. So, I feel like artificial intelligence has really made me trust those results more, that a positive is a positive and negative could potentially be a negative.